November 12, 2019
Gossamer Bio Announces Third Quarter 2019 Financial Results
– Clinical programs on track for multiple topline data releases in 2020 – – Entered clinical trial collaboration with Merck…
Pharmaceuticals, Biotechnology and Life Sciences
– Clinical programs on track for multiple topline data releases in 2020 – – Entered clinical trial collaboration with Merck…
Completed enrollment of an ongoing non-IND clinical study of AXA1125/AXA1957 in more than 100 adult subjects with NAFLD Announced intent…
– Presentation to be webcast on www.exelixis.com – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey,…
NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications,…
SALT LAKE CITY–(BUSINESS WIRE)–PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today reported…
–SYNB1618 solid oral bridging study ongoing and SYNB1891 immuno-oncology study open – – Company ends 3Q2019 with approximately $139 million…
Conference Call Today at 4:30 p.m. ET SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing…
XERAVA™ Carton Sales Grew over 30% Compared with Second Quarter of 2019 Increased Formulary Uptake, with a 99% Success Rate…
Chairman and Chief Executive Officer Paul Tufano to accept award during inaugural Diversity & Inclusion Awards Gala PHILADELPHIA–(BUSINESS WIRE)–#AmeriHealthCaritas—AmeriHealth Caritas,…
OAKLAND, Calif.–(BUSINESS WIRE)–#CWCI–The prevalence of opioids in California workers’ comp lost-time claims has dropped 51% over the past decade, reducing…